CLINICAL_TRIALS
trial_result
· 2018-02-01
Clinical Trial Update: Neoadjuvant Propanolol in Breast Cancer [Phase 2]
Summary
A Phase 2 neoadjuvant trial of propranolol in breast cancer was terminated; results were posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Texas Tech University Health Sciences Center, El Paso | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-02-01